Although we support the reissued “B” grade recommendation for screening for chlamydia and gonorrhea in all sexually active ages 24 and younger, we disagree that women ages 25 and over should only be screened if at high risk. We suggest that a “C” recommendation for men may capture that health care providers should assess patients’ risk factors and suggest screening accordingly.
Read More »